Detalhe da pesquisa
1.
Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice.
Am J Pathol
; 193(1): 11-26, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36243043
2.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37386786
3.
Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation.
Liver Int
; 44(2): 433-445, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38010893
4.
Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.
Dig Dis Sci
; 68(1): 87-97, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35579795
5.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
J Hepatol
; 77(2): 353-364, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35367282
6.
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.
Hepatology
; 74(6): 3269-3283, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34129689
7.
Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom.
Clin Gastroenterol Hepatol
; 19(4): 768-776.e10, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32562892
8.
TGF-ß2 silencing to target biliary-derived liver diseases.
Gut
; 69(9): 1677-1690, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31992593
9.
Primary sclerosing cholangitis.
Lancet
; 391(10139): 2547-2559, 2018 06 23.
Artigo
Inglês
| MEDLINE | ID: mdl-29452711
10.
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.
Clin Gastroenterol Hepatol
; 17(7): 1379-1387.e3, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30557739
11.
The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility.
Hepatology
; 68(4): 1487-1497, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29663477
12.
Fatigue in chronic liver disease: New insights and therapeutic approaches.
Liver Int
; 39(1): 6-19, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29935104
13.
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
Gut
; 67(9): 1568-1594, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29593060
14.
Access to care in rare liver diseases: New challenges and new opportunities.
J Hepatol
; 68(3): 577-585, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29113911
15.
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
Hepatology
; 63(3): 930-50, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26223498
16.
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
Dig Dis
; 35(4): 359-366, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28468009
17.
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Dig Dis
; 35(3): 267-274, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28249258
18.
Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma.
Hepatology
; 71(6): 2164-2166, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31872447
19.
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
BMC Gastroenterol
; 16(1): 71, 2016 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27431238
20.
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
Dig Dis Sci
; 61(10): 3037-3044, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27435324